John Kane is a Psychiatry physician affiliated with Zucker Hillside Hospital. ClinicalTrials.gov lists 5 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Research metrics aren't shown for this record. Either we found no confident publication match for this name, or more than one physician shares the matched author record. We'd rather show nothing than someone else's numbers. Why? →
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
75-59 263rd Street
The Zucker Hillside Hospital -Dept Of Psychiatry
Glen Oaks, NY 11004
Telephone
718-470-8141Registry record last updated 8 Jul 2007.
Clinical trials
- Randomized, Double-blinded, Placebo-controlled, Evaluating the Treatment With LB-102 in Patients With Acute Schizophrenia
Sponsor: LB Pharmaceuticals Inc.
- Improving Care and Reducing Cost Study
Sponsor: Northwell Health
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
23 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Alkermes, Inc.Program year20258 payments$16,383openpaymentsdata.cms.gov ↗
- Teva Pharmaceuticals USA, Inc.Program year20258 payments$15,322openpaymentsdata.cms.gov ↗
- ABBVIE INC.Program year20252 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
NIH funding
20 NIH research awards on record, funded 1985–2023 per NIH RePORTER. The latest:
- Early-phase Schizophrenia: Practice-based Research to Improve Treatment Outcomes (ESPRITO)
Feinstein Institute for Medical Research
FY2023$1,483,303R01MH120594 - Early-phase Schizophrenia: Practice-based Research to Improve Treatment Outcomes (ESPRITO)
Feinstein Institute for Medical Research
FY2022$1,480,860R01MH120594 - Early-phase Schizophrenia: Practice-based Research to Improve Treatment Outcomes (ESPRITO)
Feinstein Institute for Medical Research
FY2021$1,485,095R01MH120594
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
Philip Scheltens
Inserm
Rafael Tabarés‐Seisdedos
Universitat de València
Nick C. Fox
UK Dementia Research Institute
Perminder S. Sachdev
Department of Health and Aged Care
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”